Simplex Trading’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
14,300
-13,000
-48% -$1.31M ﹤0.01% 2208
2025
Q4
$2.79M Sell
27,300
-56,800
-68% -$5.08M ﹤0.01% 1712
2025
Q3
$5.25M Sell
84,100
-2,600
-3% -$141K ﹤0.01% 1419
2025
Q2
$4.51M Sell
86,700
-25,100
-22% -$1.12M ﹤0.01% 1435
2025
Q1
$4.76M Buy
111,800
+15,800
+16% +$682K ﹤0.01% 1337
2024
Q4
$2.93M Buy
96,000
+48,000
+100% +$1.35M ﹤0.01% 1869
2024
Q3
$1.1M Sell
48,000
-11,700
-20% -$331K ﹤0.01% 2845
2024
Q2
$1.72M Sell
59,700
-46,000
-44% -$1.07M ﹤0.01% 2348
2024
Q1
$2.18M Buy
105,700
+83,600
+378% +$1.79M ﹤0.01% 2320
2023
Q4
$597K Sell
22,100
-6,800
-24% -$178K ﹤0.01% 3506
2023
Q3
$856K Sell
28,900
-500
-2% -$17.6K ﹤0.01% 2829
2023
Q2
$1.05M Sell
29,400
-76,000
-72% -$2.18M ﹤0.01% 2547
2023
Q1
$2.47M Sell
105,400
-111,600
-51% -$3.19M ﹤0.01% 1771
2022
Q4
$5.9M Buy
217,000
+143,600
+196% +$6.57M 0.01% 1129
2022
Q3
$3.95M Sell
73,400
-44,500
-38% -$2.28M ﹤0.01% 1370
2022
Q2
$4.76M Buy
117,900
+61,100
+108% +$3.03M 0.01% 1177
2022
Q1
$3.76M Buy
56,800
+18,600
+49% +$1.27M ﹤0.01% 1492
2021
Q4
$3.82M Buy
38,200
+26,700
+232% +$2.76M ﹤0.01% 1428
2021
Q3
$1.46M Hold
11,500
﹤0.01% 2575
2021
Q2
$1.43M Buy
11,500
+11,442
+19,728% +$1.54M ﹤0.01% 2630
2021
Q1
$885K Sell
58
-120
-67% -$18.1K ﹤0.01% 2561
2020
Q4
$2.29M Sell
178
-261
-59% -$30K ﹤0.01% 1640
2020
Q3
$4.91M Buy
439
+300
+216% +$27.4K 0.01% 882
2020
Q2
$1.13M Sell
139
-190
-58% -$15.3K ﹤0.01% 2030
2020
Q1
$2.29M Sell
329
-24
-7% -$1.84K ﹤0.01% 1184
2019
Q4
$2.76M Buy
353
+102
+41% +$7.35K 0.01% 1215
2019
Q3
$1.6M Buy
251
+38
+18% +$3.35K ﹤0.01% 1518
2019
Q2
$1.84M Buy
213
+186
+689% +$14.2K 0.01% 1365
2019
Q1
$207K Buy
+27
New +$1.5K ﹤0.01% 3572

Other funds holding GH

Simplex Trading's GH Position: Q1 2026 in Review

Simplex Trading sold out of Guardant Health (GH) in Q1 2026, closing a stake of 18,994 shares — an estimated $1.91M sold.

Simplex Trading first reported a position in GH in Q1 2019 and held it in 15 quarters. The position peaked at $4M in Q3 2022. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Simplex Trading reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,994 Guardant Health shares in Q1 2026, an estimated $1.91M.
  • Simplex Trading first reported a position in Guardant Health in Q1 2019 and held it in 15 quarters.
  • Simplex Trading's Guardant Health position peaked at $4M in Q3 2022.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.